Header Logo

Connection

Roumen Balabanov to Patient Reported Outcome Measures

Back to Details
This is a "connection" page, showing publications Roumen Balabanov has written about Patient Reported Outcome Measures.
Roumen Balabanov
Connection Strength
0.036
Patient Reported Outcome Measures
  1. Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study. CNS Drugs. 2022 09; 36(9):977-993.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.